公开(公告)号：US20160144027A1

公开(公告)日：2016-05-26

申请号：US14949041

申请日：2015-11-23

Applicant: Samsung Electronics Co., Ltd. ,  Yonsei University, University-Industry Foundation (UIF)

Inventor： Seon Hui Shim ,  Ji Min Lee ,  Soo Yeon Jung ,  Woo Sun Kwon ,  Kyung Ah Kim ,  Jeong Min Kim ,  Sun Young Rha ,  Won Suk Lee

IPC: A61K39/395 ,  G01N33/574 ,  A61K31/4985

CPC classification number: A61K39/39558 ,  A61K31/00 ,  A61K31/4985 ,  A61K2039/505 ,  C07K16/2863 ,  C07K2317/24 ,  C07K2317/52 ,  C07K2317/622 ,  C07K2317/92 ,  C07K2319/00 ,  G01N33/57492 ,  G01N33/74 ,  G01N2333/65 ,  G01N2800/52 ,  A61K2300/00

Abstract: A method of preventing and/or treating a cancer, the method including co-administering a dual inhibitor of c-Met (hereinafter, ‘c-Met inhibitor’) and an IGF-1R inhibitor to a subject in need thereof and a use of IGF-1R as a marker for resistance to a c-Met inhibitor.

Abstract translation: 一种预防和/或治疗癌症的方法，所述方法包括将c-Met（以下称为“c-Met抑制剂”）和IGF-1R抑制剂的双重抑制剂共同给予有需要的受试者，以及使用 IGF-1R作为c-Met抑制剂抗性的标志物。

公开(公告)号：US09940087B2

公开(公告)日：2018-04-10

申请号：US14947082

申请日：2015-11-20

Applicant: Samsung Electronics Co., Ltd.

Inventor： Jihyoung Son ,  Namho Kim ,  Jeong Min Kim ,  Sung-Ho Shim

IPC: G09G5/00 ,  G06F3/14 ,  A63F13/26 ,  G06F3/00 ,  G06F3/041 ,  G06T1/20 ,  G06T3/40 ,  A63F13/837 ,  A63F13/323 ,  H04M1/725

CPC classification number: G06F3/1454 ,  A63F13/26 ,  A63F13/323 ,  A63F13/837 ,  A63F2300/1087 ,  A63F2300/204 ,  A63F2300/301 ,  A63F2300/303 ,  A63F2300/403 ,  A63F2300/609 ,  A63F2300/6653 ,  A63F2300/8076 ,  G06F3/005 ,  G06F3/041 ,  G06T1/20 ,  G06T3/40 ,  G09G2340/0407 ,  G09G2340/045 ,  G09G2354/00 ,  H04M1/7253 ,  H04M1/72544

Abstract: According to various embodiments, an operating method for a first electronic device may include: synchronizing a main scene displayed on a second electronic device with the progress of a specific application; determining a sub-scene relating to the main scene through the specific application; and displaying the sub-scene on the first electronic device. An operating method for an electronic device is not limited to the above described method, and other embodiments can be made within the same or similar scope as the present disclosure.

公开(公告)号：US10064939B2

公开(公告)日：2018-09-04

申请号：US14949041

申请日：2015-11-23

Applicant: Samsung Electronics Co., Ltd. ,  Yonsei University, University-Industry Foundation (UIF)

Inventor： Seon Hui Shim ,  Ji Min Lee ,  Soo Yeon Jung ,  Woo Sun Kwon ,  Kyung Ah Kim ,  Jeong Min Kim ,  Sun Young Rha ,  Won Suk Lee

IPC: A61K39/395 ,  A61K31/00 ,  C07K16/28 ,  A61K31/4985 ,  G01N33/574 ,  G01N33/74 ,  A61K39/00

Abstract: A method of preventing and/or treating a cancer, the method including co-administering a dual inhibitor of c-Met (hereinafter, ‘c-Met inhibitor’) and an IGF-1R inhibitor to a subject in need thereof and a use of IGF-1R as a marker for resistance to a c-Met inhibitor.